White labcorp logo

Exciting news: Invitae joins Labcorp to expand the future of genetic testing. Learn more

Invitae Unlock™ Cardiomyopathy and Arrhythmia Program

A new genetic testing program
US

Invitae Unlock™ Cardiomyopathy and Arrhythmia logo

Introducing the Invitae Unlock™ genetic testing program

Invitae Unlock™ program expands timely access to genetic insights for patients who may have a hereditary condition. Together, we can guide the best care path forward for patients today and help advance personal health treatment options for patients with genetic conditions.



Invitae Unlock™ Cardiomyopathy and Arrhythmia
Ensure your patients have options to access genetic testing through our new genetic testing program.

  • 1 in 5 patients with a suspected genetic cardiomyopathy or arrhythmia have a positive genetic test result.1
  • 2 in 3 of those positive results confer clinical management implications, including targeted therapy or increased risk.1
  • ~11% of patients who may have been missed using condition-specific panels were captured with comprehensive testing (like that featured in the Invitae Unlock™ program).2

Enabling access to genetic testing and counseling

Inform treatments

Guide diagnosis, risk stratification and care plans with:

  • medical guideline-based testing
  • reliable results
  • connection to clinical trials

Support better access

Ensure more individuals can benefit from genetic testing with:

  • simple, inclusive criteria
  • broad in-network insurance status
  • affordable patient pay options

Streamline your workflow

Accelerate care decisions with:

  • extensive support services
  • simple portal ordering
  • easy-to-read reports

Testing options

This program offers testing with the following panel. Learn more about the panels in our test catalog before placing your order on this program page.

How to order

  • Step 1 duotone icon

    1. Submit an order*

    Place an order online or via paper, including your patient's insurance information.

    * Invitae will determine if genetic testing is covered. If so, we will bill your patient’s insurance carrier once results have been released. If your patient does not have insurance benefits, the patient’s insurance policy does not cover genetic testing, or your patient does not meet their payer’s eligibility criteria, they may be eligible for a sponsored, no-charge testing option. Under this program, de-identified patient information and clinician contact information may be shared with third parties, such as researchers and commercial entities, regardless of the billing method used.

  • Step 2 duotone icon

    2. Collect a specimen

    Order a blood, buccal or saliva collection kit.

  • Genetic testing expert - Invitae icon

    3. Receive results

    On average, we return results within 10–21 days after receiving the specimen.

Woman smiling while providing genetic expert support

Additional resources

Intuitive services and resources, available when you need them.

Interpretation support
Reports come with clear information about potential next steps. For many results, Invitae offers detailed gene-specific guides created by experts.

Genetic counseling
Invitae’s genetic counselors can help review results and identify relevant management guidelines and resources.

Educational webinars
Stay up to date on the most important issues in genetics today by joining any of our Invitae-hosted webinars.

Next steps and additional services

References
1. Callis TE, et al. Precision medicine opportunities for familial arrhythmias and cardiomyopathies identified when cost of genetic testing is removed as a barrier. J Am Coll Cardiol. 2020;75(11)(suppl1):1-5.
2. Dellefave-Castillo LM et al. Combined cardiomyopathy and arrhythmia genetic testing identifies clinical management implications and unexpected results. Presented at: American Heart Association Scientific Sessions; Nov. 13-15, 2021 (virtual meeting).

Healthcare professionals must confirm that patients meet certain criteria to use the program. Third parties and commercial organizations may receive deidentified patient data from this program, but at no time would they receive patient identifiable information. Third parties and commercial organizations may receive contact information for healthcare professionals who use this program. Healthcare professionals and patients who participate in this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use, or support any other products or services from Invitae or from third parties or commercial organizations.